Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $2.26 billion. The enterprise value is $10.67 billion.
Important Dates
The last earnings date was Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | May 12, 2025 |
Share Statistics
Organon & Co. has 259.96 million shares outstanding. The number of shares has increased by 1.17% in one year.
| Current Share Class | 259.96M |
| Shares Outstanding | 259.96M |
| Shares Change (YoY) | +1.17% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 76.13% |
| Float | 258.77M |
Valuation Ratios
The trailing PE ratio is 3.03 and the forward PE ratio is 2.30. Organon & Co.'s PEG ratio is 1.27.
| PE Ratio | 3.03 |
| Forward PE | 2.30 |
| PS Ratio | 0.36 |
| Forward PS | 0.36 |
| PB Ratio | 4.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.91 |
| P/OCF Ratio | 2.41 |
| PEG Ratio | 1.27 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.30, with an EV/FCF ratio of 13.74.
| EV / Earnings | 14.23 |
| EV / Sales | 1.70 |
| EV / EBITDA | 6.30 |
| EV / EBIT | 7.63 |
| EV / FCF | 13.74 |
Financial Position
The company has a current ratio of 1.67, with a Debt / Equity ratio of 16.52.
| Current Ratio | 1.67 |
| Quick Ratio | 0.77 |
| Debt / Equity | 16.52 |
| Debt / EBITDA | 5.09 |
| Debt / FCF | 11.53 |
| Interest Coverage | 2.73 |
Financial Efficiency
Return on equity (ROE) is 254.24% and return on invested capital (ROIC) is 9.58%.
| Return on Equity (ROE) | 254.24% |
| Return on Assets (ROA) | 6.98% |
| Return on Invested Capital (ROIC) | 9.58% |
| Return on Capital Employed (ROCE) | 13.27% |
| Revenue Per Employee | $629,400 |
| Profits Per Employee | $75,000 |
| Employee Count | 10,000 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.05 |
Taxes
| Income Tax | -78.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.35% in the last 52 weeks. The beta is 0.70, so Organon & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -57.35% |
| 50-Day Moving Average | 12.91 |
| 200-Day Moving Average | 16.34 |
| Relative Strength Index (RSI) | 32.26 |
| Average Volume (20 Days) | 7,851,023 |
Short Selling Information
The latest short interest is 19.70 million, so 7.58% of the outstanding shares have been sold short.
| Short Interest | 19.70M |
| Short Previous Month | 15.13M |
| Short % of Shares Out | 7.58% |
| Short % of Float | 7.61% |
| Short Ratio (days to cover) | 4.41 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.29 billion and earned $750.00 million in profits. Earnings per share was $2.88.
| Revenue | 6.29B |
| Gross Profit | 3.60B |
| Operating Income | 1.40B |
| Pretax Income | 655.00M |
| Net Income | 750.00M |
| EBITDA | 1.70B |
| EBIT | 1.40B |
| Earnings Per Share (EPS) | $2.88 |
Full Income StatementBalance Sheet
The company has $547.00 million in cash and $8.96 billion in debt, giving a net cash position of -$8.41 billion or -$32.35 per share.
| Cash & Cash Equivalents | 547.00M |
| Total Debt | 8.96B |
| Net Cash | -8.41B |
| Net Cash Per Share | -$32.35 |
| Equity (Book Value) | 542.00M |
| Book Value Per Share | 2.10 |
| Working Capital | 1.76B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $938.00 million and capital expenditures -$161.00 million, giving a free cash flow of $777.00 million.
| Operating Cash Flow | 938.00M |
| Capital Expenditures | -161.00M |
| Free Cash Flow | 777.00M |
| FCF Per Share | $2.99 |
Full Cash Flow StatementMargins
Gross margin is 57.18%, with operating and profit margins of 22.23% and 11.92%.
| Gross Margin | 57.18% |
| Operating Margin | 22.23% |
| Pretax Margin | 10.68% |
| Profit Margin | 11.92% |
| EBITDA Margin | 26.93% |
| EBIT Margin | 22.23% |
| FCF Margin | 12.35% |
Dividends & Yields
This stock pays an annual dividend of $0.86, which amounts to a dividend yield of 9.87%.
| Dividend Per Share | $0.86 |
| Dividend Yield | 9.87% |
| Dividend Growth (YoY) | -23.21% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 29.89% |
| Buyback Yield | -1.17% |
| Shareholder Yield | 8.71% |
| Earnings Yield | 33.12% |
| FCF Yield | 34.32% |
Dividend DetailsAnalyst Forecast
The average price target for Organon & Co. is $18.50, which is 112.40% higher than the current price. The consensus rating is "Hold".
| Price Target | $18.50 |
| Price Target Difference | 112.40% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 0.93% |
| EPS Growth Forecast (5Y) | 5.94% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.32 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.32 |
| Piotroski F-Score | 5 |